This quality improvement study examines the standards of certification by the American Board of Dermatology for performance of micrographic dermatologic surgery.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440403 | PMC |
| http://dx.doi.org/10.1001/jamanetworkopen.2022.29795 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cotton ball application for intra-stage hemostasis in Mohs micrographic surgery.
J Dtsch Dermatol Ges
December 2024
Department of Dermatology, University of California Irvine, CA, USA.
Repair of a large dorsal mid-digit defect using a tunneled digital interpolation flap following Mohs micrographic surgery.
Int J Dermatol
December 2024
Division of Dermatology, University of Ottawa, Ottawa, ON, Canada.
Mohs Micrographic Surgery: A Brief Overview.
Semin Plast Surg
November 2024
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Mohs micrographic surgery (MMS) is a tissue-sparing skin cancer resection technique that involves 100% margin analysis. This procedure is performed in the outpatient setting under local anesthesia by dermatologic surgeons who act as both the surgeon and the pathologist. The technique allows for prompt reconstruction immediately after cancer clearance and offers the highest cure rate for many skin malignancies, including basal and squamous cell carcinoma, as well as more rare tumors.
View Article and Find Full Text PDFDisparities and longitudinal complications in opioid prescriptions after dermatologic surgery: An international propensity score-matched, retrospective cohort study.
Int J Dermatol
December 2024
Division of Dermatology, Baylor University Medical Center, Dallas, Texas, USA.
Background: In dermatology, the majority of opioid prescriptions occur in dermatologic surgery. Even short courses of opioids are linked to substance abuse. Reported rates of opioid prescription in dermatologic surgery are variable, with no consensus on when they should be prescribed.
View Article and Find Full Text PDFExploring opposing arguments in the call for randomized controlled trials to demonstrate benefit of Mohs micrographic surgery for cutaneous melanoma.
Dermatol Online J
October 2024
Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
The call for robust randomized clinical trials (RCTs) comparing Mohs micrographic surgery (MMS) with wide local excision for treatment of melanoma has stymied the development of guidelines for MMS despite growing evidence of benefit. This commentary explores the controversy by detailing opposing arguments, reviewing the relevant evidence supporting the use of MMS for early-stage melanoma, and discussing the role that RCTs may play in development of national guidelines for surgical treatment options for melanoma. Randomized clinical trials are considered the gold standard of clinical research, but there are no such trials currently to support MMS for melanoma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!